PBLA
PBLA clinical trials: Panbela Therapeutics, Inc.
Every trial on ClinicalTrials.gov where Panbela Therapeutics, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 4
- Trials linked
- 3
- As lead sponsor
- 1
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
PBLA on the catalyst calendar · PBLA registry changes
- Primary completion Aug 29, 2026Sponsor estimatePhase 2/Phase 3NCT05254171Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic CancerPanbela Therapeutics, Inc. · Pancreatic Cancer MetastaticRecruitingPBLALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 28, 2022ActualPhase 1NCT03412799Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic CancerPanbela Therapeutics, Inc. · Pancreatic Cancer MetastaticCompletedPBLALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2017ActualPhase 1NCT02657330Study of SBP-101 in Pancreatic CancerPanbela Therapeutics, Inc. · Pancreatic CancerCompletedPBLALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 4, 2027Sponsor estimatePhase 2NCT06059118Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate CancerSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Prostate CancerRecruitingPBLACollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 4 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner